| Eyes/patients |
| Total dense vitreous hemorrhage |
7 |
| Partial dense vitreous hemorrhage (2-3 quadrants) |
11 |
| |
|
| Previous complete PRP (spots) |
2323±661 (1500–3553) |
| Duration of prior complete PRP before IVB injection (months) |
11.60±11.98 |
| Duration of VH before treatment (months) |
2±1.02 |
| |
|
| Intravitreal bevacizumab injection |
|
| Single injection |
8 |
| 2 injections |
9 |
| 3 injections |
1 |
| |
|
| Indication of reinjection |
| Recurrent VH |
3 |
| Non-clearing VH |
7 |
| |
|
| Frequency of IVB reinjection (months) |
1.6±0.42 |
| Pre-injection visual acuity (logMAR) |
1.32±1.03 |
| Post-injection visual acuity (logMAR) |
1.09±1.10 |
| Follow-up period (months) |
14.50±2.56 |
| |
|
| Complication |
| Mild anterior uveitis and secondary glaucoma |
1 |
